Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
Derazantinib (ARQ 087) 用于治疗晚期或无法手术的 FGFR2 基因融合阳性肝内胆管癌
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-018-0334-0
Mazzaferro, Vincenzo; El-Rayes, Bassel F; Droz Dit Busset, Michele; Cotsoglou, Christian; Harris, William P; Damjanov, Nevena; Masi, Gianluca; Rimassa, Lorenza; Personeni, Nicola; Braiteh, Fadi; Zagonel, Vittorina; Papadopoulos, Kyriakos P; Hall, Terence; Wang, Yunxia; Schwartz, Brian; Kazakin, Julia; Bhoori, Sherrie; de Braud, Filippo; Shaib, Walid L